SEC Form 4 research
| Issuer | RELMADA THERAPEUTICS, INC. |
|---|---|
| Tickers | RLMD |
| Reporting owners | 17 |
| Officers and directors | 6 |
| Last public filing | 2026-09-11 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-11 | 2026-09-10 | Shenouda Maged | P | 79,800 | $4.25 | Not reported |
| 2026-09-11 | 2026-09-09 | Shenouda Maged | P | 120,200 | $4.2 | Not reported |
| 2026-09-11 | 2026-09-10 | TRAVERSA SERGIO | P | 100,000 | $4.1 | Not reported |
| 2026-09-11 | 2026-09-09 | TRAVERSA SERGIO | P | 100,000 | $4.18 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.